Form 4 Filing for Outlook Therapeutics, Inc. - Officer/Director Transaction

This Form 4 filing reports a transaction by Sukhtian Faisal Ghiath, a director at Outlook Therapeutics, Inc. (OTLK). On May 27, 2026, Mr. Ghiath acquired 122,174 shares of Common Stock at a price of $0.4093 per share. This transaction was a purchase (Code 'P') and resulted in direct ownership. Following this transaction, Mr. Ghiath directly owns 125,574 shares of the company's common stock. The filing is made in accordance with Section 16 of the Securities Exchange Act of 1934, indicating a change in beneficial ownership by an insider.